Categories: The Charlton Centre

Fibromyalgia and Fatigue

Fibromyalgia is commonly associated with fatigue. At the American College of Rheumatology meeting last month in Chicago, more than 1,000 posters were presented representing various rheumatic diseases.  In last week’s blog I shared a few of these findings.
This week I would like to share findings from a Rheumatology/Pain clinic in the United States where DHEA-s blood levels were taken for their fibromyalgia patients. DHEA is produced by the adrenal glands. Production decreases as we age.  Blood test results showed fibromyalgia patients had levels much lower than expected for their age.
Supplementation with non-prescription DHEA offered benefit in these patients from daytime fatigue, low energy and stamina. In Canada, DHEA is available by prescription only and must be compounded.  It is commonly prepared in a liquid form with drops being placed under the tongue once to twice daily. The blood test is readily available.

Carolyn Whiskin is the Pharmacy Manager for Charlton Health.  Carolyn specializes in the treatment of autoimmune diseases, pharmaceutical compounding, women’s health, pain and smoking cessation. Carolyn has won provincial and national awards for her commitment to patient care and public service.

admin

Recent Posts

Bimzelx Now Approved for Hidradenitis Suppurativa (HS)

Hidradenitis suppurativa (HS) is a chronic, inflammatory skin condition that can be very painful and…

4 days ago

Happy Holidays from Charlton Health

As the year comes to a close, we wish you a joyful holiday season filled…

3 weeks ago

Winrevair: A New Treatment Option for Pulmonary Arterial Hypertension (PAH)

Pulmonary arterial hypertension occurs when there is increased pressure in the small blood vessels that…

1 month ago

New Biologic Treatment for PMR (Polymyalgia Rheumatica)

Polymyalgia rheumatica (PMR) is an inflammatory condition that causes widespread joint and muscle pain along…

2 months ago

Expanded Protection: RSV Vaccine Now Approved for More Adults

Respiratory Syncytial Virus (RSV) is a common virus that can cause serious lung infections, particularly in…

2 months ago

Rinvoq: A New Oral Option for Giant Cell Arteritis

Health Canada has recently approved Rinvoq (upadacitinib) for adults living with Giant Cell Arteritis (GCA). Rinvoq…

3 months ago